Skip to main content

Table 3 Prevalence of respiratory symptoms stratified by OLD and HIV status.

From: Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV

 

OLD-

OLD+

 

HIV-

HIV+

HIV-

HIV+

N

580

243

106

45

Cough, n(%)

    

   Present

148 (25.5)

64 (26.3)

54 (50.9)

24 (53.3)

   Morning cough

93 (16.0)

38 (15.6)

35 (33.0)

17 (37.8)

≥ 4 days/week

109 (18.8)

46 (18.9)

37 (34.9)

23 (51.1)

≥ 3 months

61 (10.5)

31 (12.8)

22 (20.8)

11 (24.4)

Phlegm, n(%)

    

   Present

171 (29.5)

76 (31.3)

52 (49.1)

27 (60.0)

   Morning phlegm

101 (17.4)

44 (18.1)

39 (36.8)

18 (40.0)

≥ 4 days/week

109 (18.8)

54 (22.2)

37 (34.9)

21 (46.7)

≥ 3 months

78 (13.5)

30 (12.4)

24 (22.6)

13 (28.9)

Wheezing, n(%)

    

   Ever

200 (34.5)

87 (35.8)

65 (61.3)

27 (60.0)

   Most days and nights

61 (10.5)

31 (12.8)

30 (28.3)

15 (33.3)

   History of wheezing attack

117 (20.2)

54 (22.2)

47 (44.3)

21 (46.7)

  1. Values presented as n(%). OLD = Obstructive lung disease; HIV = human immunodeficiency virus